seri
substitut
ethyl
tertbutoxycarbonyl
amino
carbonyl
prepar
excel
yield
onepot
reaction
compound
dd
deriv
ce
deazaanalogu
bisindol
alkaloid
topsentin
screen
nation
cancer
institut
bethesda
md
usa
vitro
one
dose
primari
anticanc
assay
panel
human
tumor
cell
line
show
signific
activ
except
compound
show
moder
activ
cell
line
non
small
cell
lung
cancer
subpanel
cell
line
cn
subpanel
marin
invertebr
repres
import
sourc
bioactiv
molecul
particular
bisindol
alkaloid
figur
character
two
indol
unit
bound
spacer
posit
constitut
class
deepsea
spong
metabolit
potent
antiinflammatori
antimicrobi
antivir
antitumor
biolog
activ
first
isol
four
dragmacidin
contain
six
member
piperazin
heterocycl
ring
isol
larg
number
deep
water
spong
includ
dragmacidon
halicortex
spongosorit
hexadella
tunic
didemnum
candidum
show
among
biolog
properti
modest
cytotox
activ
success
complex
compon
famili
dragmacidin
pyrazinon
moieti
spacer
exhibit
vari
biolog
properti
inhibit
serinethreonin
protein
phosphatas
antivir
antimicrobi
anticanc
activ
nortopsentin
ac
imidazol
five
member
ring
spacer
isol
marin
spong
spongosorit
ruetzleri
show
vitro
cytotox
cell
antifung
activ
candida
albican
topsentin
bi
indolyl
imidazol
skeleton
figur
exhibit
antivir
antitumor
activ
particular
compound
vitro
activ
vesicular
stomat
viru
vsv
corona
viru
topsentin
show
vitro
cytotox
murin
tumor
cell
ic
human
tumor
cell
vivo
activ
tc
mgkg
melanoma
tc
mgkg
compound
exhibit
antiprolif
activ
human
broncopulmonari
cancer
cell
ic
valu
respect
due
interest
biolog
activ
rapid
growth
interest
synthesi
class
compound
analogu
recent
report
synthesi
antitumor
activ
bisindolyl
thiophen
pyrazol
furan
isoxazol
figur
show
inhibitori
activ
wide
rang
human
tumor
cell
line
gener
microand
submicromolar
rang
even
recent
bisindolyl
pyrrol
exhibit
concentrationdepend
antitumor
activ
toward
panel
human
tumor
cell
line
mean
ic
valu
respect
moreov
investig
human
tumor
xenograft
ex
vivo
clonogen
assay
reveal
select
antitumor
activ
thu
effort
search
novel
antitumor
compound
aim
develop
potent
select
agent
consid
good
antiprolif
activ
bisindolyl
pyrrol
design
new
analogu
indol
alkaloid
topsentin
report
herein
synthesi
ethyl
tertbutoxycarbonyl
amino
carbonyl
deriv
figur
imidazol
unit
moieti
topsentin
replac
highli
function
pyrrol
ring
two
indolyl
portion
place
adjac
posit
key
intermedi
synthesi
ethyl
tertbutoxycarbonyl
amino
carbonyl
prepar
good
yield
nmethylindol
friedelcraft
reaction
use
malonyl
dichlorid
dichloromethan
previous
report
scheme
onepot
reaction
latter
dd
tetrahydrofuran
presenc
cucl
catalyst
furnish
correspond
ethyl
mechan
latter
reaction
involv
copperpromot
attack
activ
carbon
atom
diketon
termin
carbon
heterodien
system
dd
give
adduct
intermedi
follow
intramolecular
cycliz
reaction
gener
ethyl
tertbutoxycarbonyl
amino
carbonyl
deriv
b
spontan
loss
water
molecul
provid
relat
aromat
pyrrol
scheme
five
member
ring
closur
substanti
sever
paper
previou
present
us
four
pyrrol
deriv
ce
select
singl
dose
concentr
vitro
diseaseori
antitumor
screen
full
nci
panel
human
tumor
cell
line
group
diseas
subpanel
includ
leukaemia
nonsmal
lung
colon
central
nervou
system
melanoma
ovarian
renal
prostat
breast
tumor
cell
line
result
obtain
take
consider
percent
growth
treat
cell
result
reveal
compound
test
concentr
show
growth
cell
line
cn
cancer
subpanel
nonsmal
cell
lung
cancer
subpanel
test
compound
show
signific
activ
commerci
avail
reagent
solvent
use
without
purif
dd
synthes
mixtur
ez
isom
previous
report
column
chromatographi
perform
merck
silica
gel
mesh
astm
sepacor
chromatographi
modul
prepack
cartridg
system
tlc
analysi
perform
preload
mm
glasssupport
silica
gel
plate
kieselgel
compound
visual
exposur
uv
light
dip
plate
ce
nh
mo
sulfur
acid
follow
heat
hot
plate
hnmr
cnmr
spectra
record
dmsod
cdcl
solut
bruker
ac
varian
mercuri
mhz
instrument
proton
carbon
spectra
referenc
intern
solvent
signal
use
valu
ppm
proton
middl
peak
ppm
carbon
middl
peak
dmsod
ppm
proton
ppm
carbon
middl
peak
cdcl
follow
abbrevi
use
describ
peak
pattern
appropri
singlet
doublet
triplet
q
quartet
multiplet
coupl
constant
j
given
hz
melt
point
taken
capillari
apparatu
uncorrect
ir
spectra
determin
bromoform
nujol
jasco
ftir
spectrophotomet
mass
spectra
record
ei
mode
shimadzu
gcm
spectromet
element
analys
c
h
n
within
theoret
valu
gener
procedur
prepar
solut
malonyl
dichlorid
ml
mmol
dcm
ml
ad
dropwis
cold
solut
appropri
nmethylindol
mmol
dcm
ml
reaction
mixtur
stir
h
room
temperatur
mixtur
ad
aqueou
sodium
carbon
shaken
min
extract
dcm
dri
evapor
residu
purifi
chromatographi
elut
dcmethyl
acet
give
deriv
analyt
spectroscop
data
report
elsewher
solut
appropri
mmol
thf
ml
dd
mixtur
ez
isom
mmol
cucl
mmol
ad
reaction
stir
magnet
stir
room
temperatur
h
disappear
dd
monitor
tlc
crude
mixtur
concentr
reduc
pressur
product
purifi
column
chromatographi
silica
gel
eluent
ethyl
acetatecyclohexan
human
tumor
cell
line
cancer
screen
panel
grown
rpmi
medium
contain
fetal
bovin
serum
mm
lglutamin
typic
screen
experi
cell
inocul
well
microtit
plate
plate
densiti
rang
cellswel
depend
doubl
time
individu
cell
line
cell
inocul
microtit
plate
incub
co
air
rel
humid
h
prior
addit
experiment
drug
h
two
plate
cell
line
fix
situ
tca
repres
measur
cell
popul
cell
line
time
drug
addit
tz
experiment
drug
solubil
dimethyl
sulfoxid
desir
final
maximum
test
concentr
store
frozen
prior
use
time
drug
addit
aliquot
frozen
concentr
thaw
dilut
twice
desir
final
maximum
test
concentr
complet
medium
contain
gentamicin
addit
four
log
serial
dilut
made
provid
total
five
drug
concentr
plu
control
aliquot
differ
drug
dilut
ad
appropri
microtit
well
alreadi
contain
medium
result
requir
final
drug
concentr
follow
drug
addit
plate
incub
addit
h
co
air
rel
humid
adher
cell
assay
termin
addit
cold
tca
cell
fix
situ
gentl
addit
cold
wv
tca
final
concentr
tca
incub
min
supernat
discard
plate
wash
five
time
tap
water
air
dri
sulforhodamin
b
srb
solut
wv
acet
acid
ad
well
plate
incub
min
room
temperatur
stain
unbound
dye
remov
wash
five
time
acet
acid
plate
air
dri
bound
stain
subsequ
solubil
mm
trizma
base
absorb
read
autom
plate
reader
wavelength
nm
suspens
cell
methodolog
except
assay
termin
fix
settl
cell
bottom
well
gentli
ad
tca
final
concentr
tca
use
seven
absorb
measur
time
zero
tz
control
growth
c
test
growth
presenc
drug
five
concentr
level
ti
percentag
growth
calcul
drug
concentr
level
percentag
growth
inhibit
calcul
inform
see
nci
websit
conclus
five
ethyl
tertbutoxycarbonyl
amino
carbonyl
deriv
analogu
marin
alkaloid
topsentin
imidazol
moieti
replac
pyrrol
ring
obtain
one
compound
compound
show
moder
activ
two
cell
line
belong
nci
cn
nonsmal
cell
lung
cancer
subpanel
